ERBB2 and gastric cancer: reported ERBB2-altered GAS cases were treated with the anti-HER2 antibody trastuzumab with excellent clinical outcomes, consistent with the experience in other HER2-positive cancers such as endometrial, breast and gastric cancer (33,52,53).